Deutsche Bank Ag\ Ardelyx, Inc. Transaction History
Deutsche Bank Ag\
- $262 Billion
- Q2 2025
A detailed history of Deutsche Bank Ag\ transactions in Ardelyx, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 170,566 shares of ARDX stock, worth $900,588. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170,566
Previous 307,895
44.6%
Holding current value
$900,588
Previous $1.51 Million
55.79%
% of portfolio
0.0%
Previous 0.0%
Shares
37 transactions
Others Institutions Holding ARDX
# of Institutions
222Shares Held
167MCall Options Held
517KPut Options Held
1.61M-
Black Rock Inc. New York, NY17.6MShares$92.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$84.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$79.5 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$61.6 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$60.5 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $816M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...